JPRN-jRCTs071210064招募中未知
Exploratory clinical trial of selective SGLT2 inhibitor for Glycogen Storage Disease type 1b
akanishi Koichi0 个研究点目标入组 5 人开始时间: 2021年9月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 1weeks old 至 < 50age old（—）
- 性别
- All
入选标准
- •1. Patients with Glycogen storage disease type 1b at the University ot the Ryukyus*
- •2. Patients with blood neutropenia or who need treatment with G-CSF drug
- •3. Frequnet diet, nighttime continuous nutrition, or similar diet is required
- •4. 1 week to 50 years old
- •* This research registrants Include one case of neonatal onset with severe hypoglycemia and neutropenia that required immediate living-donor liver transplantation.
排除标准
- •1. Moderate to severe renal dysfunction
- •2. Patients with severe liver dysfunction
- •3. Pregnant woman
研究者
相似试验
招募中
不适用
The clinical study to explore the effects of SGLT2-inhibitors or DPP-4 inhibitors in Japanese patients with type 2 diabetes.Type 2 diabetesJPRN-UMIN000020984Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine160
已完成
不适用
Prospective intervention study of novel SGLT-2 inhibitor ipragliflozin in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000015104Seino Naika Clinic100
已完成
不适用
The pilot study of SGLT2 selective inhibitor therapy for NAFLD patients who were complicated with T2DMAFLD patients who were complicated with T2DMJPRN-UMIN000023574Department of Hepatology, Shimane University Hospital20
已完成
不适用
Exploratory study for SGLT2 inhibitor -Glucose lowering action, influences of dietary habits/exercise habits on therapeutic effects, and treatment satisfactioJPRN-UMIN000016993Kanagawa Physicians Association150
招募中
4 期
Efficacy of SGLT2 inhibitor for Non-Alcoholic Fatty Liver Diseaseon Alcoholic Fatty Liver DiseaseC06.552.241.519C18.452.394.750.149ObesityType 2 Diabetes MellitusRBR-48rxwbCentro Educacional Hyarte